NCT04856371 2021-04-23Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast CancerHaihe Biopharma Co., Ltd.Phase 1 Unknown228 enrolled